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Figure 4
like RA-FLS in our previous study. Furthermore, we demonstrated
that only DcR3-Fc increased chondrocytes proliferation by itself.
Chondrocytes proliferation is increased by activation of ERK.
DcR3-Fc may be a possible therapy for OA.
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ANK EXPRESSION MODULATES BOTH THE
EXTRACELLULAR PYROPHOSPHATECONCENTRATION,
AND THE PHENOTYPE OF HUMAN OSTEOARTHRITIC
CHONDROCYTES
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P.G. Mitchell
Eli Lilly, Indianapolis, IN
Purpose: Chondrocyte extracellular pyrophosphate (ePPi) plays
a role in the pathology of calcium deposition diseases and,
potentially, primary osteoarthritis. [ePPi] is determined via a
number of mechanisms that regulate its generation and transport.
The purpose of the current work was to determine the effect
on ePPi and cell phenotype, after either knockdown or over
expression of the PPi transporter Ank in primary chondrocytes.
Methods: Human articular chondrocytes were isolated from car-
tilage obtained from consenting donors undergoing joint replace-
ment surgery. Bovine articular chondrocytes were isolated from
cartilage obtained from the metacarpophalangeal joint of adult
bovines. Chondrocytes were isolated using sequential digestion
with pronase and bacterial collagenase. Cell lines stably express-
ing human Ank (native or C-terminal His tag) were created via
transfection of HEK293 cells with human Ank followed by selec-
tion based on antibiotic resistance, Ank expression and PPi elab-
oration. siRNA transfections were carried out using 1.25ul/cm2 of
Dharmafect 4 lipid. Ank was overexpressed in bovine chondro-
cytes via electroporation (Amaxa) using parameters optimized for
chondrocyte expression of exogenous genes. mRNA levels were
determined via Taqman analysis of RNA prepared directly from
either cartilage explants or cell monolayers. ePPi was measured
via the enzymatic procedure of Lust and Seegmiller.
Results: HEK 293 cells engineered for stable expression of
human Ank elaborated a time dependent increase in extraceullu-
lar PPi (ePPi). Human OA chondrocytes accumulated substantial
amounts of ePPi, and expressed three genes (Ank, nucleotide py-
rophosphatase phosphodiesterase/NPP1 and tissue-nonspeciﬁc
alkaline phosphatase/TNAP) that inﬂuence PPi metabolism. Ank
siRNA effectively knocked-down Ank expression (>80%) in hu-
man OA chondrocytes and this was accompanied by > 90% inhi-
bition of [ePPi]. In human OA chondrocytes, siRNA knock-down
of TNAP, NPP1 or Ank mRNA, was achieved either individually
or in combination with each of the other two genes. Knock-down
of Ank or NPP-1, either alone or in any combination with the
other two genes, blocked the accumulation of ePPi. Knock-down
of TNAP alone had no effect on [ePPi]. Overexpression of Ank
in normal bovine chondrocytes via electroporation led to efﬁcient
expression of human Ank and this was accompanied by the
upregulation of genes related to both catabolism (cathepsin K,
MMP-13), and hypertrophy (type X collagen, tissue transglutam-
inase), and the down-regulation of genes related to anabolism
(type II collagen and aggrecan).
Conclusions: Overexpression of Ank in HEK 293 cells leads
to increased accumulation of ePPi, presumably through Ank’s
transmembrane transport of intracellular PPi (iPPi) to the extra-
cellular medium. Consistent with this concept, knock-down of Ank
expression in human OA chondrocytes blocked the accumulation
of ePPi. The mechanism of generation of iPPi for Ank transport is
unclear; however, the inhibition of ePPi by knock-down of either
Ank or NPP1 suggests that NPP1 hydrolysis of ATP to AMP
and PPi may play a role in providing substrate for Ank-mediated
PPi transport. TNAP knock-down had no effect on [ePPi], sug-
gesting that TNAP activity does not play a major role in either
generating ePPi or hydrolyzing ePPi to inorganic phosphate in
human OA chondrocytes. Overexpression of Ank in chondrocytes
drives changes in cell phenotype that are consistent with those
observed in OA i.e. increased expression of catabolic and hy-
pertrophic genes, and decreased expression of anabolic genes.
These data suggest that increased Ank expression or function
may play a role in the progression of degenerative joint diseases.
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Purpose: Progressive pseudorheumatoid dysplasia (PPRD) is
a rare childhood disease of articular cartilage. Mutations in the
gene encoding WISP-3 (Wnt1 inducible secreted protein 3), a
member of the CCN (Connective Tissue Growth Factor/Cysteine-
Rich 61/Nephroblastoma Over-expressed) family, have been
identiﬁed in several cases of PPRD. Previous work in another
laboratory suggests WISP-3 may regulate expression of type II
collagen and aggrecan in immortalised chondrocytic cell lines.
IGF-1 (Insulin-like growth factor 1) activates different signalling
pathways in chondrocytic cells to encourage proliferation and
differentiation. IGF-1 activity in cartilage depends on its bioavail-
ability and the responsiveness of chondrocytes. WISP-3 has an
IGFBP (Insulin-like growth factor binding protein) domain. There-
fore, WISP-3 may alter chondrocyte activity by modulating IGF-1
availability and signalling.
The aim of the current project is to further examine the role of
WISP-3 in chondrocyte biology and cartilage matrix turnover.
Methods: The expression of WISP-3 mRNA in osteoarthritic and
normal post mortem cartilage was determined by real time PCR.
Expression of WISP-3 protein in osteoarthritic and normal post
mortem cartilage sections was assessed by immunohistochemi-
cal staining.
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The WISP-3 gene was stably expressed in an immortalised
chondrocytic cell line (C-28/I2) to investigate the effects of WISP-
3 on chondrocyte biology. The expression of cartilage speciﬁc
genes was compared by real time PCR in clonal cells stably
transfected with WISP-3 or the empty vector alone. Results in
the WISP-3 stably expressing cells were veriﬁed by treating
untransfected parental C-28/I2 cells with recombinant human
WISP-3 protein.
The potential role of WISP-3 in cell signalling was investigated
by treating C-28/I2 cells with WISP-3 alone, IGF-1 alone or
IGF-1 and WISP-3 together. Erk1/2 phosphorylation was then
measured by western blotting after treatment for 10 minutes or 1
hour.
Results: Real time PCR revealed WISP-3 mRNA was upregu-
lated in osteoarthritic cartilage compared to normal post mortem
cartilage. Immunohistochemical staining of osteoarthritic and
post mortem cartilage sections showed WISP-3 protein was
present in damaged areas. In severely damaged cartilage sec-
tions, WISP-3 often appeared as strong halos around chondro-
cytes.
Stable over-expression of WISP-3 in C-28/I2 cells led to a down-
regulation of Col2a1 mRNA. Preliminary results suggest this
effect can also be produced by treatment of parental C-28/I2
cells with recombinant WISP-3 protein.
Treatment of C-28I/2 cells with IGF-1 induced Erk1/2 phos-
phorylation after 10 minutes. WISP-3 could also induce Erk1/2
phosphorylation, although when in combination with IGF-1 it did
not appear to enhance or prolong Erk1/2 phosphorylation.
Conclusions: Our data suggest that WISP-3 may be a marker
for damaged cartilage and may exert effects on matrix synthesis
and chondrocyte signalling. Further work is required to determine
the role of WISP-3 in cartilage matrix metabolism. We intend to
assess the effec ts of WISP-3 on metalloproteinase expression,
proliferation and IGF-1 induction of Col2a1 in C-28/I2 cells.
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Purpose: IKKα and IKKβ are essential kinases for activating NF-
κB transcription factors that regulate cellular differentiation and
inﬂammation. By virtue of their small size and ECM diffusibility
chemokines could invoke cross-talk between osteoarthritis (OA)
chondrocytes with other joint compartments and also contribute
to immune cell chemotaxis into the synovial space. Because
many chemokines are known to be direct NF-κB targets, here
we employed shRNA retroviruses to ablate the expression of
each IKK to determine their individual contributions for monocyte
chemotaxis in response to chondrocyte conditioned media.
Methods: Primary chondrocytes were derived from 6 OA pa-
tients undergoing joint arthroplasty. IKKα or IKKβ shRNAs were
stably expressed by pSuper retroviral transduction of IKKα or
IKKβ speciﬁc shOligos followed by selection of puromycin re-
sistant cells and KD efﬁciencies were veriﬁed by immunoblot-
ting. High density monolayer or micromass cultures were es-
tablished for each patient. Conditioned media was collected,
with or without 72 h of prior exposure to IL-1β. Chemotaxis
of human monocytes towards chondrocyte conditioned media
was assessed with boyden chambers. The chemokine expres-
sion repertoires under basal and stimulated conditions in wild
type and IKK KD chondrocytes were evaluated by focused
Oligo GEarrays (SuperArray) and the concentrations of monocyte
active chemokines (CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β,
CCL5/RANTES) were also quantiﬁed by Multiplex ﬂuorescence-
based assays.
Results: Penetrant IKKα or IKKβ KDs of 80-90% blunted the
monocyte chemotactic potential of chondrocyte conditioned me-
dia. Under basal conditions CCL2/MCP-1 was the chemokine
of highest concentration (nanogram levels) in wild type chon-
drocyte conditioned media, which presented the strongest asso-
ciation with monocyte chemotaxis (Spearman=0.943, p<0.05).
Interestingly CCL2/MCP-1 production was co-dependent on IKKα
and IKKβ, while stimulus induced expression of CCL3/MIP-1α,
CCL4/MIP-β and CCL5/RANTES appeared to be largely depen-
dent on IKKα and not IKKβ. Similar results were obtained for
CCL5/RANTES at the RNA level after IL-1 stimulation for either
2 or 8 hours.
Conclusions: Results of targeted retroviral mediated RNA inter-
ference revealed a co-dependency on IKKα and IKKβ for mono-
cyte chemotaxis in response to chondrocyte conditioned media,
even in the absence of an extracellular pro-inﬂammatory stimulus
(i.e., IL-1β). Interestingly at least part of the dual IKK dependency
for this inﬂammatory-like migration response was associated with
the magnitude of MCP-1 production. Moreover IKKα and IKKβ
appear to be constitutively active in OA chondrocytes, because
chondrocyte conditioned media induced a strong migration re-
sponse by primary monocytes under basal conditions, likely
reﬂecting the synovitis often complicating OA. Our ﬁndings re-
veal important roles of both NF-κB activating kinases in driving
a key inﬂammatory process underlying this debilitating disease.
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CHONDROCYTES
G. Tardif1, Z. Fan1, D. Hum1, F. Mineau1, N. Duval2,
J-P. Pelletier1, J. Martel-Pelletier1
1Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, PQ, Canada; 2Pavillon
des Charmilles, Vimont, PQ, Canada
Purpose: MMP-13 is a key protease in osteoarthritis (OA) patho-
physiology, and this protease is able to degrade a wide range
of cartilage matrix molecules. Our previous studies have shown
that human OA chondrocytes could be classiﬁed into two broad
categories, L- (Low) and H- (High) OA chondrocytes according
to their MMP-13 basal levels and IL-1β inducibility. L-OA chon-
drocytes had low MMP-13 basal levels and high IL-1β inducibility,
whereas H-OA chondrocytes showed high basal levels and low
IL-1β inducibility. Moreover, MMP-13 is regulated in H-OA chon-
drocytes by the proteins NMP4 and p130cas acting at the AGRE
site in the MMP-13 promoter. The aim of this study was to identify
factors involved in MMP-13 regulation in human L-OA chondro-
cytes and to determine the effect of IL-1β on these factors and
their roles. Furthermore, the effects of these factors were also
assessed on the expression of other MMPs.
Methods: Gel shift assays were done with AGRE-oligonu-
cleotides and human L-OA chondrocyte nuclear extracts; the
